Airna Therapeutics

Airna Therapeutics develops RNA-editing medicines that precisely repair disease-causing genetic variants to restore normal protein function.

This animation explains the biological basis of Alpha-1 antitrypsin deficiency (AATD)—an inherited disorder causing serious lung and liver disease—and illustrates how Airna's approach corrects the underlying genetic error to restore functional protein production, balancing scientific precision with broad accessibility.

Project Use & Impact: Used in investor pitches, partnership discussions, and patient advocacy outreach to communicate Airna's therapeutic approach to diverse stakeholders in the rare disease and biotech communities.

Key Challenge: Making novel RNA-editing technology scientifically credible yet accessible to non-specialist audiences.

Art Direction, Illustration: Neda Ivanova
Animation, storyboard, sound design: Life Science Animation

Note: This project is currently in development.